{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:52:29Z","timestamp":1790898749674,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD016226-01A1"],"award-info":[{"award-number":["1S10OD016226-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10RR-026377-01"],"award-info":[{"award-number":["1S10RR-026377-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD010678\\u201301"],"award-info":[{"award-number":["1S10OD010678\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2U19AG055373"],"award-info":[{"award-number":["2U19AG055373"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R61NS130199"],"award-info":[{"award-number":["1R61NS130199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Results in Chemistry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rechem.2025.102162","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:31:45Z","timestamp":1740771105000},"page":"102162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors"],"prefix":"10.1016","volume":"15","author":[{"given":"Yijiang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bahraminejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayijiang","family":"Taledaohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rechem.2025.102162_bb0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/acs.accounts.9b00024","article-title":"Protein arginine deiminases (PADs): biochemistry and chemical biology of protein Citrullination","volume":"52","author":"Mondal","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.rechem.2025.102162_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.rechem.2025.102162_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-021-01373-z","article-title":"Histone citrullination: a new target for tumors","volume":"20","author":"Zhu","year":"2021","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00018-022-04126-3","article-title":"Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives","volume":"79","author":"Ciesielski","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.rechem.2025.102162_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030335","article-title":"Structure-activity relationship of PAD4 inhibitors and their role in tumor immunotherapy","volume":"16","author":"Jia","year":"2024","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.rechem.2025.102162_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112414","article-title":"PAD4 and its inhibitors in Cancer progression and prognosis","volume":"14","author":"Zhu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"51","key":"10.1016\/j.rechem.2025.102162_bb0035","doi-asserted-by":"crossref","first-page":"49562","DOI":"10.1074\/jbc.M208795200","article-title":"Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes","volume":"277","author":"Nakashima","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1083\/jcb.200806072","article-title":"Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation","volume":"184","author":"Wang","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.rechem.2025.102162_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fimmu.2019.00423","article-title":"Caught in a trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus","volume":"10","author":"Chapman","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0050","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.rechem.2025.102162_bb0055","doi-asserted-by":"crossref","first-page":"1425363","DOI":"10.3389\/fimmu.2024.1425363","article-title":"CXCR1 and CXCR2 are potential neutrophil extracellular trap-related treatment targets in ulcerative colitis: insights from Mendelian randomization, colocalization and transcriptomic analysis","volume":"15","author":"Xv","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2337\/db20-0421","article-title":"Peptidylarginine deiminase inhibition prevents diabetes development in NOD mice","volume":"70","author":"Sodr\u00e9","year":"2021","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-215302","article-title":"Peptidylarginine deiminase and Alzheimer\u2019s disease","volume":"85","author":"Wang","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.rechem.2025.102162_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.rechem.2025.102162_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115826","article-title":"Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis","volume":"168","author":"Jia","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.rechem.2025.102162_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113840","article-title":"Peptidylarginine deiminases 4 as a promising target in drug discovery","volume":"226","author":"Yang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt 3","key":"10.1016\/j.rechem.2025.102162_bb0085","article-title":"Peptidylarginine deiminase (PAD): a promising target for chronic diseases treatment","volume":"278","author":"Mansouri","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.rechem.2025.102162_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cbic.200900698","article-title":"Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation","volume":"11","author":"Knuckley","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.rechem.2025.102162_bb0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2024.09.009","article-title":"Neutrophil extracellular traps promote M1 macrophage polarization in gouty inflammation via targeting hexokinase-2","volume":"224","author":"Tan","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.rechem.2025.102162_bb0100","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","article-title":"Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice","volume":"74","author":"Knight","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.rechem.2025.102162_bb0105","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1021\/acs.chemrev.5b00003","article-title":"Chemical biology of protein arginine modifications in epigenetic regulation","volume":"115","author":"Fuhrmann","year":"2015","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.rechem.2025.102162_bb0110","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1021\/acs.jmedchem.7b00274","article-title":"Development of a selective inhibitor of protein arginine deiminase 2","volume":"60","author":"Muth","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.rechem.2025.102162_bb0115","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.2147\/IJN.S255546","article-title":"TAT-modified gold nanoparticles enhance the antitumor activity of PAD4 inhibitors","volume":"15","author":"Song","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.rechem.2025.102162_bb0120","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.apsb.2021.11.006","article-title":"Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment","volume":"12","author":"Zhu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.rechem.2025.102162_bb0125","series-title":"The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics","first-page":"1","article-title":"Drug metabolism functionalization (phase I) reactions","author":"Talevi","year":"2021"},{"issue":"22","key":"10.1016\/j.rechem.2025.102162_bb0130","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/bi700095s","article-title":"Protein arginine deiminase 4: evidence for a reverse protonation mechanism","volume":"46","author":"Knuckley","year":"2007","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.rechem.2025.102162_bb0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nsmb799","article-title":"Structural basis for ca(2+)-induced activation of human PAD4","volume":"11","author":"Arita","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"39","key":"10.1016\/j.rechem.2025.102162_bb0140","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1021\/bi061180d","article-title":"Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization","volume":"45","author":"Luo","year":"2006","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.rechem.2025.102162_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/cb200258q","article-title":"Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors","volume":"7","author":"Jones","year":"2012","journal-title":"ACS Chem. Biol."}],"container-title":["Results in Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211715625001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211715625001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:43:36Z","timestamp":1790282616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211715625001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S2211715625001456"],"URL":"https:\/\/doi.org\/10.1016\/j.rechem.2025.102162","relation":{},"ISSN":["2211-7156"],"issn-type":[{"value":"2211-7156","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New structural scaffolds to enhance the metabolic stability of arginine-derived PAD4 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Results in Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rechem.2025.102162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102162"}}